NodThera Announces First Patients Dosed in RESOLVE-2 Clinical Trial Evaluating Oral NT-0796 in Combination with a GLP-1 Receptor Agonist

NT-0796 is an oral, brain-penetrant NLRP3 inhibitor that selectively regulates chronic inflammation, a key driver of cardiometabolic diseases ...
BioSpace

Bayer Gets FDA Nod for Novel Drug to Treat Hot Flashes

Lynkuet is the first FDA-approved therapy that blocks both the neurokinin 1 and neurokinin 3 receptors to treat hot flashes.
Fierce Pharma

With FDA nod, Bayer's Lynkuet enters US market for nonhormonal menopause symptom meds

On Friday, the FDA approved Bayer’s dual neurokinin (NK) targeted therapy elinzanetant, which will now be marketed in the U.S ...
FiercePharma

Alcon gains first FDA prescription drug nod since Novartis split, scoring with drops for dry eye disease

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first FDA approval for a prescription drug, scoring a nod for dry eye disease (DED) ...